A £35bn plan to fill the UK with 14 mini nuclear reactors

Polish billionaire Michał Sołowow’s SGE plans to invest about £35bn to deploy 14 GE Vernova Hitachi BWRX-300 small nuclear reactors across three UK sites, targeting first power in 2034. If executed, the project would represent a major shift in UK power infrastructure capacity, though details and regulatory timelines remain unspecified.

Analysis

This is better read as a credibility event for the nuclear supply chain than as a near-term earnings driver. For GEV, the value is in increasing the probability that its SMR platform becomes a repeatable, exportable standard; that can support backlog quality and multiple expansion even if the first cash flows are many years away. HTHIY gets some option value, but the market impact is likely diluted inside a much broader conglomerate story.

The second-order winners are the adjacent industrials that would participate if this moves from concept to financing: heavy forgings, reactor components, controls, and EPC capacity. The likely losers are competing SMR developers and high-cost gas peakers if policymakers treat this as a credible path to baseload decarbonization. But that positive read only holds if the project survives the usual failure points: licensing slippage, inflation in capex, and a financing structure that does not quietly push risk back onto the public sector.

The consensus may be overrating the headline and underrating the execution hurdle. The real catalyst path is not first power in 2034; it is whether there are binding site, permitting, and offtake milestones over the next 1-3 quarters that convert narrative into order visibility. If those do not materialize, the move should fade; if they do, the market could start pricing a broader European SMR platform rather than a single UK project.

Key Decisions for Investors

• Buy GEV on any post-headline weakness for a 6-12 month hold; this is a multiple/optionality trade, not an earnings trade. Thesis breaks if the next two quarters fail to produce binding FID or financing progress.
• Relative-value: long GEV / short SMR over the next 3-6 months. Favor the industrial platform with real manufacturing and service leverage over the higher-beta pure-play nuclear story; exit if SMR gains a clear regulatory or utility-backed commercialization edge.
• If volatility is cheap, use GEV 12-18 month call spreads rather than outright equity to express the nuclear optionality with defined downside. This is best as a small convexity sleeve, not a core position.
• No urgent trade in HTHIY; treat it as a watch item until there is evidence of meaningful economic participation. If the stock lags GEV materially on follow-through order news, HTHIY becomes a potential underperformer within the pair.